Amgen Inc (AMGN · NASDAQ)
AMGN · MARKET VIEW
Market view · as of Oct 5, 2026
Revenue (TTM)
$38.09B
+9.5% YoY
Gross margin
71.9%
EPS (latest q)
$6.29
vs $5.60 est · beat
52-wk position
74.6%
-9.2% vs 52w high · -9.2% 1mo
Price (last ~year)
Amgen reported a strong June quarter, with revenue of $10.05B and net income of $2.38B, and has beaten earnings estimates in all of its last four reports, including $6.29 versus $5.60 expected most recently. Earnings grew 64.9% year over year on 9.5% revenue growth, with TTM revenue at $38.09B, a 71.9% gross margin, and ROE of 91.5%. Leverage stands at 3.3x debt/EBITDA on $57.30B of total debt, offset by $13.99B in cash and $3.49B in quarterly free cash flow. The stock closed at $403.04, down 9.2% over the past month but up 11.5% over three months, trading 11.6% above its 200-day SMA with an analyst target of $390.94.
Valuation
- Market cap
- $217.90B
- P/E
- 25.06
- PEG
- 2.451
- P/B
- 18.78
- P/S
- 5.72
- EV/EBITDA
- 14.92
- Beta
- 0.426
- Analyst target
- $390.94
Quality & returns
- Gross margin
- 71.9%
- Operating margin
- 35.5%
- Profit margin
- 23.0%
- ROE
- 91.5%
- ROA
- 8.7%
Price movement
- Last
- $403.04
- 1-month
- -9.2%
- 3-month
- +11.5%
- RSI (14)
- 63
- vs SMA200
- +11.6%
- 52-wk position
- 74.6% -9.2% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $10.05B | $3.51B | $2.38B | $3.44B |
| 2026-03-31 | $8.62B | $2.67B | $1.82B | $3.86B |
| 2025-12-31 | $9.90B | $3.94B | $1.33B | $3.30B |
| 2025-09-30 | $9.56B | $2.53B | $3.22B | $5.91B |
Recent news
- Somewhat-Bullish How Investors Are Reacting To Regeneron Pharmaceuticals (REGN) Sanofi Alliance Expansion · 2026-10-04
- Somewhat-Bullish Amgen announces Sjögren's results as Amgen stock trades flat at EUR 358.63 · 2026-10-04
- Somewhat-Bullish NOVARTIS AG N (NOTA.F) Q2 FY2026 earnings call transcript · 2026-10-04
- Somewhat-Bullish David J. Taylor Purchases Amgen and Home Depot Stocks, Sells Marathon Petroleum · 2026-10-03
- Neutral Amgen (NASDAQ:AMGN) Stock Purchase Disclosed by Rep. David Taylor · 2026-10-03
- Neutral Home Depot (NYSE:HD) Stock Purchase Reported by Rep. David Taylor · 2026-10-03
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)